Most newly diagnosed patients with epilepsy do gain lasting control of their seizures, even if their first medication doesn’t work.

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue ...

This challenges the belief that patients who fail to respond to multiple drugs have little chance for relief It may take longer than previously thought for anti-seizure drugs to show a benefit, the ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that its lead product candidate, NRTX-1001, ...

The treatment for adult epilepsy patients 'Excoprijeong (Senovamate)' has been approved as the 41st new drug developed in Korea. The Ministry of Food and Drug Safety said the drug is authorized as an ...

For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...

University of British Columbia researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease. The findings, published today in Alzheimer's Research & Therapy, reinforce the ...

The antiepileptic drug market is poised for steady expansion. Estimated at USD 19.7 billion in 2025, the market’s steady CAGR ...

Military veterans who develop epilepsy following a traumatic brain injury might be more likely to die earlier than others ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and may come with significant side effects. New options in use or under ...